Global disease experts say little is known about China's experience with long-term COVID effects thought to have afflicted millions with debilitating fatigue, brain fog and other symptoms
Lower risk of hospital admission from omicron, UK says
There is a lower risk of hospitalisation for people with the omicron coronavirus variant compared to Delta, but the higher transmissibility of omicron could still lead to significant numbers needing hospital treatment, the UK government said.
Published : 23 Dec 2021, 05:46 PM
Updated : 23 Dec 2021, 05:46 PM
Analysis of preliminary data by the UK Health Security Agency (UKHSA) showed an individual with omicron was estimated to be between 31 percent and 45 percent less likely to attend hospital compared to someone with Delta, and 50 to 70 percent less likely to be admitted.
UKHSA Chief Executive Jenny Harries said on Thursday it was "an encouraging early signal that people who contract the omicron variant may be at a relatively lower risk of hospitalisation than those who contract other variants."
"However, it should be noted both that this is early data and more research is required to confirm these findings," she said.
The agency said evidence showed protection against symptomatic disease waned after the second dose of a COVID-19 vaccine, and then improved after the booster.
But the data suggested the extra protection started to wane more rapidly against omicron than delta, being about 15-25 percent lower from 10 weeks after the booster dose, it said.
RELATED STORIES
The demonstrations helped to end COVID restrictions but failed to achieve lasting political change, six participants based in China and overseas say
The agency seeks details on an increase in respiratory illnesses and reported clusters of pneumonia in children, which its China office called a ‘routine’ check
The inquiry is examining the government's response to the coronavirus pandemic that shut large sections of the economy and killed more than 220,000 people in Britain
